Stem cell technologies in human health: Boon or bane?


The stem cells of an organism only possess extraordinary capacity to change into different cell types during the early life and growth of an organism. When these stem cells divide into different new cells, these either remain as stem cells or develop to become other cells with specialized function. For this reason, stem cells offer direct relevance to human health, as theoretically, using stem cell technology, different organs are expected to be regenerated. To this, the Human Embryonic Stem Cells (HESCs) are natural pluripotent cell, but ethical issues covering many countries have put research work on a bit back-foot. However, the Induced Pluripotent Stem Cells (iPSCs) technology has completely revitalized the world to use this technology universally and it therefore seems that more research on this technology will surely be of enormous help in public health. In addition, application of the stem cell technology in personalized-medicine has been started recently. In this concern, the stem cell banking facilities have provided new avenues for preserving the cord blood of the new-borne child and treat them in future by using her/his own preserved stem cells. However, like all new technologies, the output from stem cell research requires to be evaluated more closely. Furthermore, with proper guidelines on ethical issues and extended research following these strategies, the stem cell technology is expected to not only be of huge benefit to human health, but also the benefit can be extended to the survival of endangered animals as well.

Share and Cite:

Tripathi, M. and Singh, S. (2015) Stem cell technologies in human health: Boon or bane?. Journal of Biosciences and Medicines, 3, 16-24. doi: 10.4236/jbm.2015.311002.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Carlson, B.M. (2007) Stem Cells, Plasticity, and Regeneration, Principles of Regenerative Biology. Acedemic Press, 239-258.
[2] King, R.S. and Newmark, P.A. (2012) Cell Biology of Regeneration. Journal of Cell Biology, 196, 553-562.
[3] Prabhakaran, M.P., Venugopal, J., Ghasemi-Mobarakeh, L., Kai, D., Jin, G. and Ram Krishna, S. (2012) Stem Cells and Nanostructures for Advanced Tissue Regeneration. Advanced Polymer Science, 246, 21-62.
[4] Barrere, F., Van-Blitterswijk, C.A. and Groot, K.A. (2006) Bone Regeneration: Molecular and Cellular Interactions with Calcium Phosphate Ceramics. International Journal of Nanomedicine, 1, 317-332.
[5] Prasad, P., Desai, R., Bansal, S., Shirsat, P. and Raipure, P. (2015) Stem Cells—Emerging Concepts in Dentistry. Annals of Medicinal Chemistry and Research, 1, 1006.
[6] Dubie, T., Admassu, B., Sisay, T. and Shiferav, H. (2014) Basic Biology and Therapeutic Application of Stem Cells in Various Human and Animal Diseases. Journal of Cell Biology and Genetics, 4, 40-52.
[7] Singh, R.K., Gaikwad, S.M., Chatterjee, S. and Ray, P. (2014) Stem Cells: The Holy Grail of Regenerative Medicine. Engineering in Translational Medicine, 4471-4472.
[8] Mitalipov, S. and Wolf, D. (2009) Totipotencty Pluripotency and Nuclear Reprogramming. Advances in Biochemical Engineering/Biotechnology, 114, 185-199.
[9] Lin, H.T., Makotootsu, O. and Nakauchi, H. (2011) Stem Cell Therapy: An Exercise in Patience and Prudence. Philosophical Transitions B, 0334.
[10] Ning, L., Goossens, E., Geens, M., Saen, D.V. and Tournaye, H. (2012) Spermatogonial Stem Cells as a Source for Regenerative Medicine. Science Direct Middle East Fertility Society Journal, 17, 1-7.
[11] Zhang, X., Stojkovic, P., Przyborski, S., Cooke, M., Armstrong, L., Lako, M., et al. (2006) Derivation of Human Embryonic Stem Cells from Developing and Arrested Embroys. Stem Cell, 24, 2669-2676.
[12] Stadtfeld, M. and Hochedlinger, K. (2010) Induced Pluripotency: History, Mechanism, and Applications. Genes and Development, 24, 2239-2263.
[13] Patel, M. and Yang, S. (2010) Advances in Reprogramming Somatic Cells to Induced Pluripotent Stem Cells. Stem Cell Review, 6, 367-380.
[14] Tada, M., Tada, T., Lefebvre, L., Barton, S.C. and Azim, S.M. (1997) Embryonic Germ Cells Induce Epigenetic Reprogramming of Somatic Nucleus in Hybrid Cells. EMBO Journal, 16, 6510-6520.
[15] Cyranoski, D. (2014) The Black Box of Reprogramming. Nature, 516, 162-164.
[16] Tsai, C.C. and Hung, S.C. (2012) Functional Roles of Pluripotency Transcription Factors in Mesenchymal Stem Cells. Cell Cycle, 11, 3711-3712.
[17] Kim, J.S., Choi, H.W., Choi, S. and Do, J.T. (2011) Reprogrammed Pluripotent Stem Cells from Somatic Cells. International Journal of Stem Cells, 4, 1-8.
[18] Ramsden, C.M., Powner, M.B., Carr, A.J.F., Smart, M.J.K., Cruz, L. and Coffey, P.J. (2013) Stem Cells in Retinal Regeneration: Past, Present and Future. Development, 140, 2576-2585.
[19] Velasco, I., Salazar, P., Giorgetti, A., Ramos-Mejía, V., Castano, J., Romero-Moya, D., et al. (2014) Concise Review: Generation of Neurons from Somatic Cells of Healthy Individuals and Neurological Patients through Induced Pluripotency or Direct Conversion. Stem Cells, 32, 2811-2817.
[20] Robinton, D.A. and Daley, G.Q. (2012) The Promise of Induced Pluripotent Stem Cells in Research and Therapy. Nature, 481, 295-305.
[21] Yamanaka, S. (2012) Induced Pluripotent Stem Cells: Past, Present, and Future. Cell Stem Cell, 10, 678-684.
[22] Patel, M. and Yang, S. (2010) Advances in Reprogramming Somatic Cells to Induced Pluripotent Stem Cells. Stem Cell Review, 6, 367-380.
[23] Plath, K. and Lowry, W.E. (2011) Progress in Understanding Reprogramming to the Induced Pluripotent State. Nature Reviews Genetics, 12, 253-265.
[24] Perán, M., María, A., García, M.A., López-Ruiz, E., Bustamante, M., Jiménez, G., et al. (2012) Functionalized Nanostructures with Application in Regenerative Medicine. International Journal of Molecular Science, 13, 3847-3886.
[25] Okita, K. and Yamanaka, S. (2011) Induced Pluripotent Stem Cells: Opportunities and Challenges. Philosophical Transactions of the Royal Society B: Biological Sciences, 366, 2183-2197.
[26] Ban, H., Nishishita, N., Fusaki, N., Tabata, T., Saeki, K., Shikamura, M., et al. (2011) Efficient Generation of Transgene-Free Human Induced Pluripotent Stem Cells (iPSCs) by Temperature-Sensitive Sendai Virus Vectors. Proceedings of the National Academy of Sciences of the United States of America, 108, 14234-14239.
[27] Somers, J., Jean, J.C., Sommer, C.A., Omari, A., Ford, C.C., Mills, J.A., et al. (2010) Generation of Transgene-Free Lung Disease-Specific Human iPS Cells Using a Single Excisable Lentiviral Stem Cell Cassette. Stem Cell, 28, 1728- 1740.
[28] Yeo, J.C. and Ng, H.H. (2013) The Transcriptional Regulation of Pluripotency. Cell Research, 23, 20-32.
[29] Huang, G.T.J. (2010) Induced Pluripotent Stem Cells—A New Foundation in Medicine. Journal of Experimental and Clinical Medicine, 2, 202-217.
[30] Phillips, M.J., Perez, E.T., Martin, J.M., Reshel, S.T., Wallace, K.A., Capowski, E.E., et al. (2014) Modeling Human Retinal Development with Patient-Specific Induced Pluripotent Stem Cells Reveals Multiple Roles for Visual System Homeobox 2. Stem Cells, 32, 1480-1492.
[31] Wu, S.M. and Hochedlinger, K. (2011) Harnessing the Potential of Induced Pluripotent Stem Cells for Regenerative Medicine. Nature Cell Biology, 13, 497-505.
[32] Khan, N., Pande, V. and Das, A. (2013) NAT2 Sequence Polymorphisms and Acetylation Profiles in Indians. Pharmacogenomics, 14, 289-303.
[33] Kalow, W. (2006) Pharmacogenetics and Pharmacogenomics: Origin, Status, and the Hope for Personalized Medicine. The Pharmacogenomics Journal, 6, 162-165.
[34] Li, Y., Wu, W.H., Hsu, C.W., Nguyen, H.V., Tsai, Y.T. and Chan, L. (2014) Gene Therapy in Patient-Specific Stem Cell Lines and a Preclinical Model of Retinitis Pigmentosa with Membrane Frizzled-Related Protein Defects. Molecular Therapy, 22, 1688-1697.
[35] Chun, Y.S., Byun, K. and Lee, B. (2011) Induced Pluripotent Stem Cells and Personalized Medicine: Current Progress and Future Perspective. Anatomy & Cell Biology, 44, 245-255.
[36] Abdullah, A.I., Pollock, A. and Sun, T. (2012) The Path from Skin to Brain: Generation of Functional Neurons from Fibroblasts. Molecular Neurobiology, 45, 586-595.
[37] Medvedev, S.P., Shevchenko, A.I. and Zakian, S.M. (2010) Induced Pluripotent Stem Cells: Problems and Advantages When Applying Them in Regenerative Medicine. Acta Naturae, 2, 18-28.
[38] Teye, K., Tsuneoka, M., Arima, N., Koda, Y., Nakamura, Y., Ueta, Y., et al. (2004) Increased Expression of a Myc target Gene Mina53 in Human Colon Cancer. American Journal of Pathology, 164, 205-216.
[39] Zhang, M., Yang, C., Huixian, L.H. and Sun, Y. (2013) Induced Pluripotent Stem Cells Are Sensitive to DNA Damage. Genomics, Proteomics Bioinformatics, 11, 320-326.
[40] Diekman, B.O., Christoforou, N., Willard, V.P., Sun, H., Sanchez-Adams, J., Leong K.W., et al. (2012) Cartilage Tissue Engineering Using Differentiated and Purified Induced Pluripotent Stem Cells. Proceedings of the National Academy of Sciences of the United States of America, 109, 19172-19177.
[41] Logeart-Avramoglou, D., Anagnostou, F., Bizios, R. and Petite, H. (2005) Engineering Bone: Challenges and Obstacles. Journal of Cellular and Molecular Medicine, 9, 72-84.
[42] Schuster, J.A., Stupnikov, M.R., Ma, G., Liao, W., Lai, R., Ma, Y., et al. (2012) Expansion of Hematopoietic Stem Cells for Transplantation: Current Perspectives. Experimental Hematology and Oncology, 1, 12.
[43] Blenkinsop, T.A., Corneo, B., Temple, S. and Stern, J.H. (2012) Ophthalmologic Stem Cell Transplantation Therapies. Regenerative Medicine, 7, 32-39.
[44] Koch, P., Kokaia, Z., Lindvall, O. and Brüstle, O. (2009) Emerging Concepts in Neural Stem Cell Research: Autologous Repair and Cell-Based Disease Modelling. Lancet Neurology, 8, 819-829.
[45] Gluckman, E., Ruggeri, A., Rocha, V., Baudoux, E., Boo, M., Kurtzberg, J., et al. (2011) Family-Directed Umbilical Cord Blood Banking. Haematologica, 96, 1700-1707.
[46] Geraghty, R.J., Capes-Davis, A., Davis, J.M., Downward, J., Freshney, R.I., Knezevic, I., et al. (2014) Guidelines for the Use of Cell Lines in Biomedical Research. British Journal of Cancer, 111, 1021-1046.
[47] Barrilleaux, B. and Knoepfler, P.S. (2011) Inducing iPSCs to Escape the Dish. Stem Cell, 9, 103-111.
[48] Platt, J.L. (2010) Antibodies in Transplantation. Discovery Medicine, 10, 125-133.
[49] Nakano-Okuno, M., Borah, B.R. and Ichiro, N.I. (2014) Ethics of iPSC-Based Clinical Research for Age-Related Macular Degeneration: Patient-Centered Risk-Benefit Analysis. Stem Cell Reviews, 10, 743-752.
[50] Yee, J. (2010) Turning Somatic Cells into Pluripotent Stem Cells. Nature Education, 3, 25.
[51] Ben-Nun, I.F., Montague, S.C., Houck, M.L., Tran, H.T., Garitaonandia, I., Leonardo, T.R., et al. (2011) Induced Pluripotent Stem Cells from Highly Endangered Species. Nature Methods, 8, 829-831.
[52] Callaway, E. (2011) Could Stem Cells Rescue an Endangered Species? Nature, Published Online.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.